TipRanks
Advertisement
Advertisement
Psyence Biomedical announces exclusive U.S. Ibogaine license for TIRC
PremiumThe FlyPsyence Biomedical announces exclusive U.S. Ibogaine license for TIRC
25d ago
Psychedelic: Optimi completes psilocybin production for Phase 2 trial
Premium
The Fly
Psychedelic: Optimi completes psilocybin production for Phase 2 trial
29d ago
Psyence Biomedical Launches Texas Ibogaine Unit and Commits Up to US$5 Million in PsyLabs
Premium
Company Announcements
Psyence Biomedical Launches Texas Ibogaine Unit and Commits Up to US$5 Million in PsyLabs
30d ago
Psyence Biomedical files to sell 1.15M common shares for holders
PremiumThe FlyPsyence Biomedical files to sell 1.15M common shares for holders
2M ago
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update
Premium
Company Announcements
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update
3M ago
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan
Premium
Company Announcements
Psyence Biomedical Corrects Technical Error in 2023 Equity Incentive Plan
5M ago
PBM, CMPS, ATAI: Psychedelic Biotech Stocks Soar after White House Order for Faster FDA Reviews
PremiumMarket NewsPBM, CMPS, ATAI: Psychedelic Biotech Stocks Soar after White House Order for Faster FDA Reviews
6M ago
Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal
Premium
Company Announcements
Psyence Biomedical Adds Intraday Equity Purchase Option in White Lion Financing Deal
6M ago
Psyence Biomedical provides update on position in global ibogaine market
Premium
The Fly
Psyence Biomedical provides update on position in global ibogaine market
6M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―